ARTICLE
18 August 2016

New Hampshire Law Clarifies Prescribing Of Controlled Substances By Telehealth

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
Effective August 12, 2016, modifications to a New Hampshire telemedicine prescribing law allow providers delivering services by means of telemedicine to prescribe non-opioid controlled drugs classified in schedules II through IV.
United States Food, Drugs, Healthcare, Life Sciences
Alexis S. Gilroy’s articles from Jones Day are most popular:
  • with readers working within the Technology and Oil & Gas industries
Jones Day are most popular:
  • in Africa

Effective August 12, 2016, modifications to a New Hampshire telemedicine prescribing law allow providers delivering services by means of telemedicine to prescribe non-opioid controlled drugs classified in schedules II through IV, as long as they are treating a patient with whom the prescribers have an in-person practitioner-patient relationship and are monitoring and providing follow-up care. This expands the prior version of the law, which limited the prescribing of such medications by means of telehealth to providers treating patients at a state-designed community mental health center or substance abuse program, allowing for greater utilization of telehealth with existing patients.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More